Research ArticleOriginal Research
Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties
Peter Hanlon, Terence J. Quinn, Katie I. Gallacher, Phyo K. Myint, Bhautesh Dinesh Jani, Barbara I. Nicholl, Richard Lowrie, Roy L. Soiza, Samuel R. Neal, Duncan Lee and Frances S. Mair
The Annals of Family Medicine March 2020, 18 (2) 148-155; DOI: https://doi.org/10.1370/afm.2501
Peter Hanlon
1General Practice and Primary Care, Institute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland,
United Kingdom
MScTerence J. Quinn
2Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland,
United Kingdom
MDKatie I. Gallacher
1General Practice and Primary Care, Institute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland,
United Kingdom
PhDPhyo K. Myint
3Institute of Applied Health Sciences, University of Aberdeen, Foresterhill, Aberdeen, Scotland,
United Kingdom
4Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, Scotland,
United Kingdom
MDBhautesh Dinesh Jani
1General Practice and Primary Care, Institute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland,
United Kingdom
PhDBarbara I. Nicholl
1General Practice and Primary Care, Institute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland,
United Kingdom
PhDRichard Lowrie
5Pharmacy and Prescribing Support Unit, NHS Greater Glasgow and Clyde, West Glasgow Ambulatory Care Unit, Glasgow, Scotland,
United Kingdom
PhDRoy L. Soiza
3Institute of Applied Health Sciences, University of Aberdeen, Foresterhill, Aberdeen, Scotland,
United Kingdom
4Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, Scotland,
United Kingdom
MRCPSamuel R. Neal
3Institute of Applied Health Sciences, University of Aberdeen, Foresterhill, Aberdeen, Scotland,
United Kingdom
Duncan Lee
6School of Mathematics and Statistics, University of Glasgow, University Place, Glasgow, Scotland,
United Kingdom
PhDFrances S. Mair
1General Practice and Primary Care, Institute of Health and Wellbeing, University of Glasgow, Glasgow, Scotland,
United Kingdom
MD
Published eLetters
If you would like to comment on this article, click on Submit a Response to This article, below. We welcome your input.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Annals of Family Medicine: 18 (2)
Vol. 18, Issue 2
March/April 2020
Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties
Peter Hanlon, Terence J. Quinn, Katie I. Gallacher, Phyo K. Myint, Bhautesh Dinesh Jani, Barbara I. Nicholl, Richard Lowrie, Roy L. Soiza, Samuel R. Neal, Duncan Lee, Frances S. Mair
The Annals of Family Medicine Mar 2020, 18 (2) 148-155; DOI: 10.1370/afm.2501
Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties
Peter Hanlon, Terence J. Quinn, Katie I. Gallacher, Phyo K. Myint, Bhautesh Dinesh Jani, Barbara I. Nicholl, Richard Lowrie, Roy L. Soiza, Samuel R. Neal, Duncan Lee, Frances S. Mair
The Annals of Family Medicine Mar 2020, 18 (2) 148-155; DOI: 10.1370/afm.2501
Jump to section
Related Articles
Cited By...
- A qualitative exploration of barriers to efficient and effective Structured Medication Reviews in Primary Care: Findings from the DynAIRx study
- Association between recently raised anticholinergic burden and risk of acute cardiovascular events: nationwide case-case-time-control study
- Managing drugs with anticholinergic activity
- Anticholinergic burden in middle and older age is associated with lower cognitive function, but not with brain atrophy
- Association between anticholinergic burden and dementia in UK Biobank
- Increase in anticholinergic burden in the UK from 1990 to 2015: a UK Biobank study
- Variation in VKORC1 is associated with vascular dementia